Interestingly, Verges et al. underscore that the impact of diabetes mellitus on LDL-ApoB catabolism may overshadow the effects of PCSK9, as serum PCSK9 seems to affect LDL-ApoB-100 catabolism only in individuals without T2DM [155]. Here, PCSK9 is linked to type 2 diabetes mellitus.